Insights

AI Drug Discovery BenevolentAI is a pioneer in using advanced AI for drug discovery, offering a unique selling point for pharmaceutical companies looking to enhance their R&D capabilities through innovative technology solutions.

Established Technology The Benevolent PlatformTM, a validated AI drug discovery technology, provides a competitive edge for companies seeking proven and reliable tech partners to accelerate drug development processes and increase success rates.

Financially Stable With revenue in the range of $50-100 million and significant funding of $90 million, BenevolentAI presents a financially stable and robust partner for collaborations or investments in the pharmaceutical industry.

Market Positioning Among similar companies, BenevolentAI stands out with its employee strength and revenue figures, indicating a strong market presence and growth potential that can be leveraged by partners seeking to align with successful players in the industry.

Global Reach Headquartered in London, BenevolentAI provides a strategic entry point for international pharmaceutical businesses looking to tap into the UK market and expand their footprint through partnerships or acquisitions with a leading AI-driven drug discovery company.

BenevolentAI Tech Stack

BenevolentAI uses 8 technology products and services including Hotjar, Google Hosted Libraries, MySQL, and more. Explore BenevolentAI's tech stack below.

  • Hotjar
    Analytics
  • Google Hosted Libraries
    Content Delivery Network
  • MySQL
    Database
  • Qualys
    Network Security
  • Windows Server 2012
    Operating Systems
  • Microsoft Azure
    Platform As A Service
  • TypeScript
    Programming Languages
  • C++
    Programming Languages

Media & News

BenevolentAI's Email Address Formats

BenevolentAI uses at least 2 format(s):
BenevolentAI Email FormatsExamplePercentage
First.Last@benevolent.aiJohn.Doe@benevolent.ai
95%
First.Middle@benevolent.aiJohn.Michael@benevolent.ai
2%
First.Middle.Last@benevolent.aiJohn.Michael.Doe@benevolent.ai
2%
First.MiddleLast@benevolent.aiJohn.MichaelDoe@benevolent.ai
1%
First.Last@benevolent.comJohn.Doe@benevolent.com
75%
First@benevolent.comJohn@benevolent.com
21%
FirstLast@benevolent.comJohnDoe@benevolent.com
4%

Frequently Asked Questions

Where is BenevolentAI's headquarters located?

Minus sign iconPlus sign icon
BenevolentAI's main headquarters is located at Maple Street 4-8 London, Greater London W1T 5HD GB. The company has employees across 6 continents, including EuropeNorth AmericaAfrica.

What is BenevolentAI's stock symbol?

Minus sign iconPlus sign icon
BenevolentAI is a publicly traded company; the company's stock symbol is BAI.AS.

What is BenevolentAI's official website and social media links?

Minus sign iconPlus sign icon
BenevolentAI's official website is benevolent.com and has social profiles on LinkedIn.

How much revenue does BenevolentAI generate?

Minus sign iconPlus sign icon
As of April 2025, BenevolentAI's annual revenue reached $75M.

What is BenevolentAI's NAICS code?

Minus sign iconPlus sign icon
BenevolentAI's NAICS code is 5112 - Software Publishers.

How many employees does BenevolentAI have currently?

Minus sign iconPlus sign icon
As of April 2025, BenevolentAI has approximately 201 employees across 6 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Executive Officer: B. S.Chief People Officer: A. F.Chief Technology Officer: J. M.. Explore BenevolentAI's employee directory with LeadIQ.

What industry does BenevolentAI belong to?

Minus sign iconPlus sign icon
BenevolentAI operates in the Software Development industry.

What technology does BenevolentAI use?

Minus sign iconPlus sign icon
BenevolentAI's tech stack includes HotjarGoogle Hosted LibrariesMySQLQualysWindows Server 2012Microsoft AzureTypeScriptC++.

What is BenevolentAI's email format?

Minus sign iconPlus sign icon
BenevolentAI's email format typically follows the pattern of . Find more BenevolentAI email formats with LeadIQ.

How much funding has BenevolentAI raised to date?

Minus sign iconPlus sign icon
As of April 2025, BenevolentAI has raised $90M in funding. The last funding round occurred on Sep 17, 2019 for $90M.

When was BenevolentAI founded?

Minus sign iconPlus sign icon
BenevolentAI was founded in 2013.
BenevolentAI

BenevolentAI

Software DevelopmentGreater London, United Kingdom201-500 Employees

BenevolentAI is a pioneer and leader in applying advanced AI to drug discovery and development. 

In a world where drug development failure rate exceeds 90% and thousands of complex diseases lack treatment, our technology can increase the probability of success and reduce timelines. 

Our proprietary Benevolent PlatformTM is one of the industry's most established and validated AI drug discovery technologies. Expertise across Target Identification, Chemistry and Drug Repurposing enables us to deliver across the entire R&D lifecycle. We unite science and technology to serve patients with complex diseases – because it matters.

BenevolentAI is headquartered in London, UK.

Section iconCompany Overview

Headquarters
Maple Street 4-8 London, Greater London W1T 5HD GB
Stock Symbol
BAI.AS
NAICS Code
5112 - Software Publishers
Founded
2013
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $90M

    BenevolentAI has raised a total of $90M of funding over 3 rounds. Their latest funding round was raised on Sep 17, 2019 in the amount of $90M.

  • $50M$100M

    BenevolentAI's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $90M

    BenevolentAI has raised a total of $90M of funding over 3 rounds. Their latest funding round was raised on Sep 17, 2019 in the amount of $90M.

  • $50M$100M

    BenevolentAI's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.